Cancer immunotherapy, which uses drugs that stimulate the body’s immune cells to attack tumors, is a promising approach to treating many types of cancer. However, it doesn’t work well for some tumors, including ovarian cancer.
To elicit a better response, MIT researchers have designed new nanoparticles that can deliver an immune-stimulating molecule called IL-12 directly to ovarian tumors. When given along with immunotherapy drugs called checkpoint inhibitors, IL-12 helps the immune system launch an attack on cancer cells.
Studying a mouse model of ovarian cancer, the researchers showed that this combination treatment could eliminate metastatic tumors in more than 80 percent of the mice. When the mice were later injected with more cancer cells, to simulate tumor recurrence, their immune cells remembered the tumor proteins and cleared them again.
“What’s really exciting is that we’re able to deliver IL-12 directly in the tumor space. And because of the way that this nanomaterial is designed to allow IL-12 to be borne on the surfaces of the cancer cells, we have essentially tricked the cancer into stimulating immune cells to arm themselves against that cancer,” says Paula Hammond, an MIT Institute Professor, MIT’s vice provost for faculty, and a member of the Koch Institute for Integrative Cancer Research.
Hammond and Darrell Irvine, a professor of immunology and microbiology at the Scripps Research Institute, are the senior authors of the new study, which appears today in Nature Materials. Ivan Pires PhD ’24, now a postdoc at Brigham and Women’s Hospital, is the lead author of the paper.
“Hitting the gas”
Most tumors express and secrete proteins that suppress immune cells, creating a microenvironment in which the immune response is weakened. One of the main players that can kill tumor cells are T cells, but they get sidelined or blocked by the cancer cells and are unable to attack the tumor. Checkpoint inhibitors are an FDA-approved treatment designed to take those brakes off the immune system by removing the immune-suppressing proteins so that T cells can mount an attack on tumor cells
For some cancers, including some types of melanoma and lung cancer, removing the brakes is enough to provoke the immune system into attacking cancer cells. However, ovarian tumors have many ways to suppress the immune system, so checkpoint inhibitors alone usually aren’t enough to launch an immune response.
“The problem with ovarian cancer is no one is hitting the gas. So, even if you take off the brakes, nothing happens,” Pires says.
IL-12 offers one way to “hit the gas,” by supercharging T cells and other immune cells. However, the large doses of IL-12 required to get a strong response can produce side effects due to generalized inflammation, such as flu-like symptoms (fever, fatigue, GI issues, headaches, and fatigue), as well as more severe complications such as liver toxicity and cytokine release syndrome — which can be so severe they may even lead to death.
In a 2022 study, Hammond’s lab developed nanoparticles that could deliver IL-12 directly to tumor cells, which allows larger doses to be given while avoiding the side effects seen when the drug is injected. However, these particles tended to release their payload all at once after reaching the tumor, which hindered their ability to generate a strong T cell response.
In the new study, the researchers modified the particles so that IL-12 would be released more gradually, over about a week. They achieved this by using a different chemical linker to attach IL-12 to the particles.
“With our current technology, we optimize that chemistry such that there’s a more controlled release rate, and that allowed us to have better efficacy,” Pires says.
The particles consist of tiny, fatty droplets known as liposomes, with IL-12 molecules tethered to the surface. For this study, the researchers used a linker called maleimide to attach IL-12 to the liposomes. This linker is more stable than the one they used in the previous generation of particles, which was susceptible to being cleaved by proteins in the body, leading to premature release.
To make sure that the particles get to the right place, the researchers coat them with a layer of a polymer called poly-L-glutamate (PLE), which helps them directly target ovarian tumor cells. Once they reach the tumors, the particles bind to the cancer cell surfaces, where they gradually release their payload and activate nearby T cells.
Disappearing tumors
In tests in mice, the researchers showed that the IL-12-carrying particles could effectively recruit and stimulate T cells that attack tumors. The cancer models used for these studies are metastatic, so tumors developed not only in the ovaries but throughout the peritoneal cavity, which includes the surface of the intestines, liver, pancreas, and other organs. Tumors could even be seen in the lung tissues.
First, the researchers tested the IL-12 nanoparticles on their own, and they showed that this treatment eliminated tumors in about 30 percent of the mice. They also found a significant increase in the number of T cells that accumulated in the tumor environment.
Then, the researchers gave the particles to mice along with checkpoint inhibitors. More than 80 percent of the mice that received this dual treatment were cured. This happened even when the researchers used models of ovarian cancer that are highly resistant to immunotherapy or to the chemotherapy drugs usually used for ovarian cancer.
Patients with ovarian cancer are usually treated with surgery followed by chemotherapy. While this may be initially effective, cancer cells that remain after surgery are often able to grow into new tumors. Establishing an immune memory of the tumor proteins could help to prevent that kind of recurrence.
In this study, when the researchers injected tumor cells into the cured mice five months after the initial treatment, the immune system was still able to recognize and kill the cells.
“We don’t see the cancer cells being able to develop again in that same mouse, meaning that we do have an immune memory developed in those animals,” Pires says.
The researchers are now working with MIT’s Deshpande Center for Technological Innovation to spin out a company that they hope could further develop the nanoparticle technology. In a study published earlier this year, Hammond’s lab reported a new manufacturing approach that should enable large-scale production of this type of nanoparticle.
The research was funded by the National Institutes of Health, the Marble Center for Nanomedicine, the Deshpande Center for Technological Innovation, the Ragon Institute of MGH, MIT, and Harvard, and the Koch Institute Support (core) Grant from the National Cancer Institute.
News
New nanoparticles stimulate the immune system to attack ovarian tumors
Cancer immunotherapy, which uses drugs that stimulate the body’s immune cells to attack tumors, is a promising approach to treating many types of cancer. However, it doesn’t work well for some tumors, including ovarian [...]
New Drug Kills Cancer 20,000x More Effectively With No Detectable Side Effects
By restructuring a common chemotherapy drug, scientists increased its potency by 20,000 times. In a significant step forward for cancer therapy, researchers at Northwestern University have redesigned the molecular structure of a well-known chemotherapy drug, greatly [...]
Lipid nanoparticles discovered that can deliver mRNA directly into heart muscle cells
Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have stalled, largely due to the difficulty of delivering treatments at the cellular level. Now, a UC Berkeley-led [...]
The basic mechanisms of visual attention emerged over 500 million years ago, study suggests
The brain does not need its sophisticated cortex to interpret the visual world. A new study published in PLOS Biology demonstrates that a much older structure, the superior colliculus, contains the necessary circuitry to perform the [...]
AI Is Overheating. This New Technology Could Be the Fix
Engineers have developed a passive evaporative cooling membrane that dramatically improves heat removal for electronics and data centers Engineers at the University of California San Diego have created an innovative cooling system designed to greatly enhance [...]
New nanomedicine wipes out leukemia in animal study
In a promising advance for cancer treatment, Northwestern University scientists have re-engineered the molecular structure of a common chemotherapy drug, making it dramatically more soluble and effective and less toxic. In the new study, [...]
Mystery Solved: Scientists Find Cause for Unexplained, Deadly Diseases
A study reveals that a protein called RPA is essential for maintaining chromosome stability by stimulating telomerase. New findings from the University of Wisconsin-Madison suggest that problems with a key protein that helps preserve chromosome stability [...]
Nanotech Blocks Infection and Speed Up Chronic Wound Recovery
A new nanotech-based formulation using quercetin and omega-3 fatty acids shows promise in halting bacterial biofilms and boosting skin cell repair. Scientists have developed a nanotechnology-based treatment to fight bacterial biofilms in wound infections. The [...]
Researchers propose five key questions for effective adoption of AI in clinical practice
While Artificial Intelligence (AI) can be a powerful tool that physicians can use to help diagnose their patients and has great potential to improve accuracy, efficiency and patient safety, it has its drawbacks. It [...]
Advancements and clinical translation of intelligent nanodrugs for breast cancer treatment
A comprehensive review in "Biofunct. Mater." meticulously details the most recent advancements and clinical translation of intelligent nanodrugs for breast cancer treatment. This paper presents an exhaustive overview of subtype-specific nanostrategies, the clinical benefits [...]
It’s Not “All in Your Head”: Scientists Develop Revolutionary Blood Test for Chronic Fatigue Syndrome
A 96% accurate blood test for ME/CFS could transform diagnosis and pave the way for future long COVID detection. Researchers from the University of East Anglia and Oxford Biodynamics have created a highly accurate [...]
How Far Can the Body Go? Scientists Find the Ultimate Limit of Human Endurance
Even the most elite endurance athletes can’t outrun biology. A new study finds that humans hit a metabolic ceiling at about 2.5 times their resting energy burn. When ultra-runners take on races that last [...]
World’s Rivers “Overdosing” on Human Antibiotics, Study Finds
Researchers estimate that approximately 8,500 tons of antibiotics enter river systems each year after passing through the human body and wastewater treatment processes. Rivers spanning millions of kilometers across the globe are contaminated with [...]
Yale Scientists Solve a Century-Old Brain Wave Mystery
Yale scientists traced gamma brain waves to thalamus-cortex interactions. The discovery could reveal how brain rhythms shape perception and disease. For more than a century, scientists have observed rhythmic waves of synchronized neuronal activity [...]
Can introducing peanuts early prevent allergies? Real-world data confirms it helps
New evidence from a large U.S. primary care network shows that early peanut introduction, endorsed in 2015 and 2017 guidelines, was followed by a marked decline in clinician-diagnosed peanut and overall food allergies among [...]
Nanoparticle blueprints reveal path to smarter medicines
Lipid nanoparticles (LNPs) are the delivery vehicles of modern medicine, carrying cancer drugs, gene therapies and vaccines into cells. Until recently, many scientists assumed that all LNPs followed more or less the same blueprint, [...]
